Voters in one key state will decide this November on a ballot initiative aiming to control the wild spikes in drug prices. Will consumer outrage at the ever-rising cost of medication translate into support for similar actions across the country? Or will Big Pharma and the politicians it funds nip this burgeoning movement in the bud?